eMedicine Specialties > Orthopedic Surgery > Knee

Osteonecrosis, Knee: Treatment

Author: Amar Rajadhyaksha, MD, Resident, Department of Orthopedic Surgery, New York Medical College
Coauthor(s): Michael Mont, MD, Associate Professor, Department of Orthopaedic Surgery, Johns Hopkins Medical Institution; Michael Levine, MD, Chairman, Department of Orthopedic Surgery, Western Pennsylvania Hospital
Contributor Information and Disclosures

Updated: Aug 15, 2008

Treatment

Medical Therapy

Nonoperative and operative treatment options are available for osteonecrosis of the knee. Spontaneous osteonecrosis of the knee (SPONK) and secondary osteonecrosis can be treated nonoperatively when the patient is asymptomatic. However, once a patient becomes symptomatic, treatment options for the 2 entities differ.

Nonoperative treatment has been shown to produce good results in symptomatic patients with SPONK. Treatment encompasses a conservative regimen of protected weightbearing with crutches, analgesics, nonsteroidal anti-inflammatory medications, and physical therapy focused on strengthening the quadriceps and hamstring muscles. Lotke et al reported on 87 knees with SPONK: 36 of these knees were treated nonoperatively, with only 1 progressing to arthroplasty; the 35 remaining knees did well.16,17,18

Outcomes of nonoperative treatment in symptomatic secondary osteonecrosis are relatively poor. One study of 51 knees with secondary osteonecrosis treated nonoperatively reported that 31 knees eventually required arthroplasty. Therefore, operative therapy usually is recommended once the patient is symptomatic.

Pharmacotherapy aimed at the putative pathophysiology of the disease has had mixed results. Medications that have been used include nifedipine and lipid-lowering agents such as gemfibrozil (Lopid).

Surgical Therapy

Arthroscopy

Arthroscopic debridement for the treatment of osteonecrosis of the knee has had mixed results. Arthroscopy may not alter the natural course of the disease. Patients with SPONK may have degenerative tears of the menisci. Debridement of these tears does not improve osteonecrosis of the bone. In addition, partial meniscectomy has been hypothesized to cause further degeneration of the knee joint. Thus, arthroscopy is controversial, with questions arising on the possibility of increased interosseous pressure.

Osteochondral grafts

Reports on results with osteochondral allografts have been discouraging for both spontaneous osteonecrosis of the knee (SPONK) and secondary osteonecrosis. Bayne et al used fresh allografts in 6 knees with SPONK, resulting in only 1 good result.19 The authors suspect that these results were due to the poor compliance of elderly patients, resulting in allograft fragmentation. The 3 knees with steroid-induced secondary osteonecrosis also failed the grafting procedure. This may be due to continued use of corticosteroids, which may lead to poor vascularization of the graft and subsequent subsidence.

Some surgeons have focused on using osteochondral autografts. This procedure, commonly referred to as OATS (osteochondral autologous transfer system), was first introduced by Matsusue in 1993.20 Using this procedure, Hangody et al reported a 2-5 year follow-up with good or excellent results in up to 90% of cases.21 Other grafting methods may improve results, but further studies are required.

High tibial osteotomy

High tibial osteotomy (HTO) has been used in patients with SPONK, with encouraging results.22 Aglietti et al described 31 patients treated with high tibial osteotomy, with 21 of these knees having ancillary bone grafting.8 Of the 31 knees, 87% had excellent to good results at a mean follow-up of 6.2 years, and only 2 knees progressed to arthroplasty. Use of high tibial osteotomy in secondary osteonecrosis is limited because most of these patients have bicondylar femoral involvement and also may have tibial involvement.

Core decompression

The principle behind core decompression is reduction of interosseous pressure, thereby restoring adequate circulation. This procedure has been used with some success in the earlier stages of osteonecrosis. Core decompression is a lesser procedure than total knee arthroplasty and has been shown to delay the need for joint replacement.

Core decompression has been used with some success in SPONK. Forst et al reported successful outcomes in their study of 16 knees, in which core decompression of the femoral condyle was performed in precollapsed lesions.23 Results have not been as encouraging in SPONK as in secondary osteonecrosis. Therefore, it should be reserved for refractory cases.

Mont et al reported on 79 knees that were treated for secondary osteonecrosis.24 Forty-seven knees were treated with core decompression, and 32 were treated nonoperatively. For core decompression, clinical success was achieved in 73% (34 of 47) of knees (good to excellent Knee Society Scores) at a mean follow-up of 11 years (range of 4-16 y). Radiographically, 17 of the 47 (36%) knees progressed to Ficat and Arlet stage III or IV, as opposed to 24 of 32 knees (75%) treated nonoperatively.

Unicondylar (unicompartmental) knee arthroplasty

Unicondylar arthroplasty has been used with success in SPONK, as the disease usually is confined to 1 condyle (see Image 3).25 This procedure is not, however, recommended for secondary osteonecrosis, as the disease can affect both condyles.26 Marmor reported an 89% success rate in a study of 34 knees with medial femoral condyle osteonecrosis treated with unicondylar replacement.27

Total knee arthroplasty

Knee arthroplasty is indicated in the late stages of the disease, when patients have severe pain that does not respond to other treatments (see Image 4). Total knee arthroplasty is an appropriate intervention for late-stage secondary osteonecrosis with degenerative changes, for patients with severe pain, or for those with functional disability. It has had varying success with SPONK. Bergman and Rand reported that 87% of 38 knees treated with total knee arthroplasties had excellent or good results.28 Of those knees, 27 had SPONK and 9 had secondary osteonecrosis. These results were inferior to those of total knee replacements performed for other diagnoses.

Ritter et al compared 32 knees with SPONK to 63 osteoarthritic knees.29 The success rate was 82% in SPONK knees, with no statistical significance in success rates between the 2 groups. For secondary osteonecrosis, Mont et al reported on 31 knees treated with total knee arthroplasty; all of these patients had a history of corticosteroid use.30 After 8.2 years of mean follow-up, results excellent to good in 55% of knees.

Preoperative Details

Core decompression

Determining areas of pain on the tibia and/or femur is essential. The lesion should be delineated carefully on MRI examination to determine which areas need to be cored and to determine extent of involvement.

Intraoperative Details

Core decompression

Intraoperatively, when coring the knee, a tourniquet is applied but rarely is inflated. For femoral coring, a small incision is made on the lateral or medial side under fluoroscopic control, just above the flare of the condyle (see Image 5). Then, a 3- to 6-mm Michelle trephine is inserted through the metaphyseal flare into the lateral and medial condyles up to within a few millimeters of the subchondral plate.

For tibial coring, the trephine is introduced through a small incision just medial to the tibial tubercle, being sure to avoid the medial saphenous nerve. The trephine then is guided into the medial and lateral plateaus. It is helpful to turn the trocar while advancing it within the bone to clear the teeth and obtain the best biopsy possible.

Postoperative Details

Core decompression

Fifty percent weightbearing with a cane or crutch for 6 weeks is advised, after which the patient may return to full weightbearing.

Follow-up

For excellent patient education resources, visit eMedicine's Foot, Ankle, Knee, and Hip Center, Breaks, Fractures, and Dislocations Center, Arthritis Center, and Bone Health Center. Also, see eMedicine's patient education articles Knee Pain, Knee Injury, and Knee Joint Replacement.

Complications

Core decompression

Complications are minimal when the surgeon is experienced. The operation causes minimal blood loss and is a quick procedure. Possible complications include infection, fracture, and failure of the procedure to alleviate symptoms.

Total knee arthroplasty

Although more extensive than core decompression, this is a relatively safe and effective procedure. Possible problems include, but are not limited to, reactions to anesthesia, deep venous thrombosis (DVT), injury to a nerve or blood vessel (peroneal nerve palsy), fracture, infection, swelling, and dislocation of the patella.

More on Osteonecrosis, Knee

Overview: Osteonecrosis, Knee
Workup: Osteonecrosis, Knee
Treatment: Osteonecrosis, Knee
Follow-up: Osteonecrosis, Knee
Multimedia: Osteonecrosis, Knee
References
[ CLOSE WINDOW ]

References

  1. Ahlback S, Bauer GC, Bohne WH. Spontaneous osteonecrosis of the knee. Arthritis Rheum. Dec 1968;11(6):705-33. [Medline].

  2. Zizic TM, Marcoux C, Hungerford DS. Corticosteroid therapy associated with ischemic necrosis of bone in systemic lupus erythematosus. Am J Med. Nov 1985;79(5):596-604. [Medline].

  3. Soucacos PN, Beris AE, Xenakis TH, et al. Knee osteonecrosis: Distinguishing features and differential diagnosis. In: Urbaniak JR, Jones JP, eds. Osteonecrosis: Etiology, Diagnosis, and Treatment. Rosemont, IL: The American Academy of Orthopaedic Surgeons;1997: 413-24.

  4. Williams JS Jr, Bush-Joseph CA, Bach BR Jr. Osteochondritis dissecans of the knee. Am J Knee Surg. Fall 1998;11(4):221-32. [Medline].

  5. Ohdera T, Miyagi S, Tokunaga M, Yoshimoto E, Matsuda S, Ikari H. Spontaneous osteonecrosis of the lateral femoral condyle of the knee: a report of 11 cases. Arch Orthop Trauma Surg. Jul 1 2008;[Medline].

  6. Sakai T, Sugano N, Nishii T, Haraguchi K, Yoshikawa H, Ohzono K. Bone scintigraphy for osteonecrosis of the knee in patients with non-traumatic osteonecrosis of the femoral head: comparison with magnetic resonance imaging. Ann Rheum Dis. Jan 2001;60(1):14-20. [Medline].

  7. Takeda M, Higuchi H, Kimura M, Kobayashi Y, Terauchi M, Takagishi K. Spontaneous osteonecrosis of the knee: histopathological differences between early and progressive cases. J Bone Joint Surg Br. Mar 2008;90(3):324-9. [Medline].

  8. Aglietti P, Insall JN, Buzzi R. Idiopathic osteonecrosis of the knee. Aetiology, prognosis and treatment. J Bone Joint Surg Br. Nov 1983;65(5):588-97. [Medline].

  9. Mont MA, Hungerford DS. Osteonecrosis of the shoulder, knee, and ankle. In JR Urbaniak and JP Jones, eds. Osteonecrosis: Etiology, Diagnosis, and Treatment. Rosemont, IL: The American Academy of Orthopaedic Surgeons;1997: 429-436.

  10. Ficat RP, Arlet J. Necrosis of the femoral head. In: Hungerford DS, ed. Ischemia and Necrosis of Bone. Baltimore: Williams and Wilkins;1980: 171-82.

  11. Ficat RP. Idiopathic bone necrosis of the femoral head. Early diagnosis and treatment. J Bone Joint Surg Br. Jan 1985;67(1):3-9. [Medline].

  12. Ficat RP. [Aseptic necrosis of the femur head. Pathogenesis: the theory of circulation]. Acta Orthop Belg. Mar-Apr 1981;47(2):198-9. [Medline].

  13. Mont MA, Hungerford DS. Non-traumatic avascular necrosis of the femoral head. J Bone Joint Surg Am. Mar 1995;77(3):459-74. [Medline].

  14. Mont MA, Rifai A, Baumgarten K. Osteonecrosis of the Knee, Insall and Scott. Surgery of the knee. 2001;438-456.

  15. Ficat RP, Arlet J. Functional investigation of bone under normal conditions. In: Hungerford DS, ed. Ischemia and Necrosis of Bone. Baltimore: Williams and Wilkins;1980: 29-52.

  16. Ecker ML, Lotke PA. Osteonecrosis of the medial part of the tibial plateau. J Bone Joint Surg Am. Apr 1995;77(4):596-601. [Medline].

  17. Lotke PA, Ecker ML. Osteonecrosis of the knee. J Bone Joint Surg [Am]. Mar 1988;70(3):470-3. [Medline].

  18. Lotke PA, Ecker ML. Osteonecrosis-like syndrome of the medial tibial plateau. Clin Orthop. Jun 1983;(176):148-53. [Medline].

  19. Bayne O, Langer F, Pritzker KP. Osteochondral allografts in the treatment of osteonecrosis of the knee. Orthop Clin North Am. Oct 1985;16(4):727-40. [Medline].

  20. Matsusue Y, Yamamo T, Hama H. Arthroscopic multiple osteochondral transplantation to the chondral defect in the knee associated with anterior cruciate ligament rupture. Arthroscopy. 1993;9:318.

  21. Hangody L, Kish G, Karpatiz. Osteochondral plugs: Autogenous osteochondral mosaicplasty for the treatment of focal chondral and osteochondral articular defects. Operative Techniques Orthop. 1997;7:12.

  22. Koshino T. The treatment of spontaneous osteonecrosis of the knee by high tibial osteotomy with and without bone-grafting or drilling of the lesion. J Bone Joint Surg [Am]. Jan 1982;64(1):47-58. [Medline].

  23. Forst J, Forst R, Heller KD, Adam G. Spontaneous osteonecrosis of the femoral condyle: causal treatment by early core decompression. Arch Orthop Trauma Surg. 1998;117(1-2):18-22. [Medline].

  24. Mont MA, Tomek IM, Hungerford DS. Core decompression for avascular necrosis of the distal femur: long term followup. Clin Orthop. Jan 1997;(334):124-30. [Medline].

  25. Parratte S, Argenson JN, Dumas J, Aubaniac JM. Unicompartmental knee arthroplasty for avascular osteonecrosis. Clin Orthop Relat Res. Nov 2007;464:37-42. [Medline].

  26. Myers TG, Cui Q, Kuskowski M, Mihalko WM, Saleh KJ. Outcomes of total and unicompartmental knee arthroplasty for secondary and spontaneous osteonecrosis of the knee. J Bone Joint Surg Am. Nov 2006;88 Suppl 3:76-82. [Medline].

  27. Marmor L. Unicompartmental arthroplasty for osteonecrosis of the knee joint. Clin Orthop. Sep 1993;(294):247-53. [Medline].

  28. Bergman NR, Rand JA. Total knee arthroplasty in osteonecrosis. Clin Orthop. Dec 1991;(273):77-82. [Medline].

  29. Ritter MA, Eizember LE, Keating EM, Faris PM. The survival of total knee arthroplasty in patients with osteonecrosis of the medial condyle. Clin Orthop Relat Res. Jun 1991;108-14. [Medline].

  30. Mont MA, Myers TH, Krackow KA. Total knee arthroplasty for corticosteroid associated avascular necrosis of the knee. Clin Orthop. May 1997;(338):124-30. [Medline].

  31. Yates PJ, Calder JD, Stranks GJ, Conn KS, Peppercorn D, Thomas NP. Early MRI diagnosis and non-surgical management of spontaneous osteonecrosis of the knee. Knee. Mar 2007;14(2):112-6. [Medline].

  32. Lotke PA, Abend JA, Ecker ML. The treatment of osteonecrosis of the medial femoral condyle. Clin Orthop Relat Res. Nov-Dec 1982;109-16. [Medline].

  33. Banzer W, Hübscher M, Schikora D. Laser-Needle Therapy for Spontaneous Osteonecrosis of the Knee. Photomed Laser Surg. Jul 22 2008;[Medline].

  34. Deie M, Ochi M, Adachi N, Nishimori M, Yokota K. Artificial bone grafting [calcium hydroxyapatite ceramic with an interconnected porous structure (IP-CHA)] and core decompression for spontaneous osteonecrosis of the femoral condyle in the knee. Knee Surg Sports Traumatol Arthrosc. Aug 2008;16(8):753-8. [Medline].

  35. Koshino T, Okamoto R, Takamura K. Arthroscopy in spontaneous osteonecrosis of the knee. Orthop Clin North Am. Jul 1979;10(3):609-18. [Medline].

  36. Miller GK, Maylahn DS, Drennan DB. The treatment of idiopathic osteonecrosis of the femoral condyle with Arthroscopic Debridement. Arthroscopy. 1986;2:21.

  37. Soucacos PN, Xenakis TH, Beris AE. Idiopathic osteonecrosis of the medial femoral condyle. Classification and treatment. Clin Orthop. Aug 1997;(341):82-9. [Medline].

  38. Zizic TM, Hungerford DS. Avascular necrosis of bone. In: Kelley WN, Harris ED, Ruddy S, Sledge CB, eds. Textbook of Rheumatology. Vol 2. Philadelphia: WB Saunders;1985: 1689-1710.

[ CLOSE WINDOW ]

Further Reading

[ CLOSE WINDOW ]

Keywords

osteonecrosis, knee osteonecrosis, osteonecrosis of knee, spontaneous osteonecrosis of the knee, SPONK, secondary osteonecrosis, avascular necrosis, AVN, aseptic necrosis, ischemic necrosis, idiopathic necrosis, knee pain, knee arthritis, bone death, mass bone death, bone disease, necrosis

[ CLOSE WINDOW ]

Contributor Information and Disclosures

Author

Amar Rajadhyaksha, MD, Resident, Department of Orthopedic Surgery, New York Medical College
Disclosure: Nothing to disclose.

Coauthor(s)

Michael Mont, MD, Associate Professor, Department of Orthopaedic Surgery, Johns Hopkins Medical Institution
Michael Mont, MD is a member of the following medical societies: American Academy of Orthopaedic Surgeons
Disclosure: Stryker Orthopaedics Consulting fee Consulting; Wright Medical Technology, Inc. Consulting fee Consulting

Michael Levine, MD, Chairman, Department of Orthopedic Surgery, Western Pennsylvania Hospital
Michael Levine, MD is a member of the following medical societies: American Academy of Orthopaedic Surgeons, American Association of Hip and Knee Surgeons, American Medical Association, Orthopaedic Research Society, Pennsylvania Medical Society, Pennsylvania Orthopaedic Society, and Phi Beta Kappa
Disclosure: encore medical Consulting fee Consulting; glaxo smith kline Honoraria Speaking and teaching

Medical Editor

Albert W Pearsall IV, MD, Associate Professor, Department of Orthopedic Surgery, University of South Alabama; Director, Section of Sports Medicine and Shoulder Service, Department of Orthopedic Surgery, University of South Alabama Medical Center
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Thomas M DeBerardino, MD, Associate Professor of Orthopaedic Surgery, University of Connecticut Health Center
Thomas M DeBerardino, MD is a member of the following medical societies: American Academy of Orthopaedic Surgeons, American Orthopaedic Association, and American Orthopaedic Society for Sports Medicine
Disclosure: Arthrex, Inc. Grant/research funds Other; Arthrex, Inc. Honoraria Speaking and teaching; Genzyme Biosurgery. Inc. Grant/research funds Other; Musculoskeletal Transplant Foundation Grant/research funds Other; Histogenics Grant/research funds None; Arthrex, Inc. Consulting fee Speaking and teaching

CME Editor

Dinesh Patel, MD, FACS, Associate Clinical Professor of Orthopedic Surgery, Harvard Medical School; Chief of Arthroscopic Surgery, Department of Orthopedic Surgery, Massachusetts General Hospital
Dinesh Patel, MD, FACS is a member of the following medical societies: American Academy of Orthopaedic Surgeons, American Association of Physicians of Indian Origin, American College of International Physicians, and American College of Surgeons
Disclosure: Nothing to disclose.

Chief Editor

Carlos J Lavernia, MD, FAAOS, Adjunct Clinical Professor, Department of Orthopedic Surgery, University of Miami School of Medicine; Medical Director, Orthopedic Institute at Mercy Hospital
Carlos J Lavernia, MD, FAAOS is a member of the following medical societies: American Academy of Orthopaedic Surgeons, American Association of Hip and Knee Surgeons, Arthritis Foundation, Biomedical Engineering Society, Florida Orthopaedic Society, and Orthopaedic Research Society
Disclosure: Zimmer Stock Implant Designer

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.